NOVEL PYRIMIDINE AND 1,3,5-TRIAZINE HYPOLIPIDEMIC AGENTS

被引:45
作者
DATRI, G [1 ]
GOMARASCA, P [1 ]
RESNATI, G [1 ]
TRONCONI, G [1 ]
SCOLASTICO, C [1 ]
SIRTORI, CR [1 ]
机构
[1] CTR E GROSSI PADLETTI,DEPT PHARMACOL,I-20129 MILAN,ITALY
关键词
D O I
10.1021/jm00378a016
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1621 / 1629
页数:9
相关论文
共 35 条
[1]  
[Anonymous], 1974, ESTIMATION CATALASE
[2]  
BONDESSON G, 1974, ACTA PHARM SUEC, V11, P417
[3]  
BOON WR, 1952, J CHEM SOC, V14, P1532
[4]   SUR UNE NOUVELLE METHODE DE DOSAGE DU CHOLESTEROL LIE AUX ALPHA-LIPOPROTEINES ET AUX BETA-LIPOPROTEINES DU SERUM [J].
BURSTEIN, M ;
SAMAILLE, J .
CLINICA CHIMICA ACTA, 1958, 3 (04) :320-327
[5]  
CAYEN MN, 1980, ANNU REP MED CHEM, V15, P162
[6]  
CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102
[7]   CLOFIBRATE, PIRINIXIL (BR-931) AND WY-14,643 DO NOT AFFECT BODY CHOLESTEROL IN SPRAGUE-DAWLEY RATS [J].
DATRI, G ;
GOMARASCA, P ;
GALIMBERTI, E ;
SIRTORI, CR ;
KRITCHEVSKY, D .
ATHEROSCLEROSIS, 1980, 37 (03) :475-483
[9]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[10]   PHARMACOLOGICAL STUDIES ON TIADENOL IN TYPE-IV PATIENTS - EVIDENCE FOR A MECHANISM OF ACTION DIFFERENT FROM OTHER LIPID-LOWERING DRUGS [J].
FRANCESCHINI, G ;
POLI, A ;
CATAPANO, AL ;
GATTI, E ;
SIRTORI, M ;
GIANFRANCESCHI, G ;
SIRTORI, CR .
ATHEROSCLEROSIS, 1981, 40 (3-4) :245-255